About the Partnership for Safe Medicines India
The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit www.safemedicinesindia.in
PSM India 1st August Newsletter
News Archive
Editor's Emulsion

Pooja Khaitan


There is an urgent need to build awareness amongst the health professionals and Patients to make the reporting system popular and efficient.
Partnership for Safe Medicines ( PSM) India is organizing a National Training Workshop on “Secured Medicines & Robust Pharmacovigilance - Key to Patient Safety & Health” , in collaboration with Government of India, State Governments, Consumer Organisations and Pharmaceutical Industry
On 23rd August at Bangalore and 26th August 2013 at Mumbai
This training initiative is to further strengthen the system and enable the healthcare providers to use the infrastructure effectively. It has been observed that Patients hardly report ADRs ( adverse drug reactions ) and the hospitals, doctors and nursing staff are also unaware about such facilities in the interest of the patients and Science of medication.
We look forward to your registering with us and being a part of this event .
BE SAFE ! BE SECURE ! See you at our event !

Best wishes ,

Pooja Khaitan
Chief Editor ,
Partnership for Safe Medicines India.


Mr. Misra at WHO award

Mr. Bejon Misra
, founder PSM India , Consumer online Foundation was  conferred with the World No Tobacco Day Award 2013 , by World Health Organisation,  for his anti tobacco campaign on Friday , 26th, July , 2013 .

Dose of the day
Call PSM India toll free helpline 1800 - 11- 4424, to bring cases of spurious medicines or any kind of adverse drug reaction to the notice of the authorities.
To register a complaint kindly visit our consumer redressal website www.consumerconexion.org
Upcoming Events

National Training Workshop on “Secured Medicines & Robust Pharmacovigilance - Key to Patient Safety & Health” Organised By Government of India and State Governments Managed By Partnership for Safe Medicines (PSM) India Initiative on 23rd August at Bangalore and 26th August 2013 at Mumbai

World Drug Safety Conference
When: September 10-12, 2013
Where: London, UK
Description: Click here>>>

Partnership for Safe Medicines Interchange
When: October 24, 2013
Where: Washington, DC
Description: Click here>>>

National Injections
FDA seals Faridabad pharma unit
CHANDIGARH, July, 2013: A team of the Food and Drug Administration (FDA), Haryana, on Wednesday raided the premises of a manufacturing unit in Faridabad and sealed it as it was found violating various provisions of the Drugs and Cosmetics Act. The unit of XL Orthomed (P) Ltd, Sarai Khawaja, Faridabad, was manufacturing sterile and non-sterile orthopedic implants, which came under the definition of 'drug', which was unlicensed, a spokesperson for the FDA said.
Read More
Woman, son die after quack administers post expiry date drip in UP
LUCKNOW, July 2013: It seems that patients in Uttar Pradesh are faced with a double whammy. While sweepers, ward boys and rickshaw-pullers treat them at government hospitals, quacks prey on them outside. A woman and her son died in Bhadohi district, about 300 kilometres from here, allegedly after being administered a saline drip by a quack on Sunday night, according to reports. Reports said Phoolmani Devi had been ill for the past few months.
Read More
Drugs seized, one held for illegal collection
DIMAPUR, July 2013 (MExN): Excise personnel posted at the Chumukedima Check-post on July 21 confiscated 33 thousand capsules of restricted pharmaceutical drug - spasmo proxyvon. The restricted drug was found in the possession of one Md. Ziaour Rahman (22 years), hailing from Lilong Turel Ahanbi, Thoubal, Manipur. According to the Excise Narcotic Cell, the accused procured the drugs from Kolkata and was taking it to Imphal.
Read More
Drug Law and Policy Injections
Government to soon notify revocation of suspension of Pioglitazone

NEW DELHI, July 2013: In a first of its kind move, the government is set to revoke the suspension order on anti-diabetes drug pioglitazone and analgin, imposed late last month. However, pharmaceutical companies selling the drug will be required to carry a box warning indicating the possible risk of bladder cancer. The decision was taken in a meeting of the government's highest advisory body on drugs, the Drugs Technical Advisory Board (DTAB), on July 19, after strong opposition from the industry as well as the medical fraternity emphasizing the need of the drug for patients in the country.

Read More
Global Injections
UK man jailed for role in fake Avastin case

UK citizen Richard Taylor has been sentenced to 18 months in prison after admitting to illegally selling US doctors a fake version of Roche's cancer drug Avastin. Taylor was also fined $800,000 for his role in the scam and ordered to forfeit his interest in approximately $3.2m in illegal proceeds, some of which was seized during the investigation at a bank in the UK. The counterfeit Avastin (bevacizumab) product, which bore the Turkish brand name Altuzan, was discovered in the US medicines supply chain last year and upon analysis was revealed to have no active ingredient.

Read More
The US General Accounting Office Releases Condemning Report On Fake Internet Pharmacies

The United States Government Accountability Office (GAO) has just released a new report on the growing threat of fake Internet pharmacies in the United States. Its findings underscore the difficulty of enforcing US laws on foreign-based Internet pharmacies, and the imperative need for public outreach to educate consumers about the dangers of counterfeit drugs. Internet pharmacies that skirt U.S. laws and pose a serious danger to consumers are a growing concern, says the Government Accountability Office in their new July 2013 report on internet pharmacies (Download GAO Internet Pharmacies 2013).

Read More
Pharma Injections
Sun Pharma recalls brain hemorrhage drug in US

NEW DELHI, July 2013: Drug major Sun Pharma has recalled certain lots of Nimodine capsules, a drug indicated to treat brain hemorrhage, in the US market due to crystal formation. As per the information available on the US Food and Drug Administration (USFDA) website, the company is recalling the Nimodine capsules, 30 mg due to “crystallization”. The recall falls under Class II category, and it is done in a situation in which the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Read More
Subscribers Symptom

We welcome your valuable contributions and news articles . Please feel free to write to THE Chief Editor at
pooja@safemedicinesindia.in regarding the same . We shall be delighted to include your articles in our next issue .

The following article has been contributed by……
Dr. M.S.Latha
Manager , Global Medical Affairs,
Dr. Reddy’s Laboratories Ltd.
Adverse Events With Statins Uncommon, Meta-Analysis Shows

An analysis of nearly a quarter million individuals treated with statin therapy in 135 randomized, controlled clinical trials has shown that the lipid-lowering drugs are associated with a small increased risk of diabetes, but there was no evidence of an increased risk of cancer.
Overall, statins were well tolerated, according to the investigators, with the analysis indicating no evidence of an increased risk of myalgia, myopathy, or rhabdomyolysis. Head-to-head comparison showed that pravastatin and simvastatin had the lowest risk of adverse events vs atorvastatin and rosuvastatin (Crestor, AstraZeneca).

Read More
This Newsletter brought to you by

Jan Aushadhi Logo

© 2011 Partnership for Safe Medicines India E-15/A, first floor, East of Kailash, New Delhi -110065
www.safemedicinesindia.in; www.safemedicines.org; www.ConsumerConexion.org
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .PSM India may not be held responsible for any article published in PSM NEWZ .